We are live on ! Find out more
CMND icon

Clearmind Medicine
CMND

7 hedge funds and large institutions have $5.45M invested in Clearmind Medicine in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% less ownership

Funds ownership: 0.03% → 0.03% (-0.01%)

1% less capital invested

Capital invested by funds: $5.49M → $5.45M (-$38.8K)

22% less funds holding

Funds holding: 9 → 7 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$68.8K
2
TSS
Two Sigma Securities
New York
+$18.3K
3
GAM
Gotham Asset Management
New York
+$1.04K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$54K
2
Citadel Advisors
Citadel Advisors
Florida
-$52.7K
3
TRCT
Tower Research Capital (TRC)
New York
-$1.29K

CMND Hedge Fund Activity: Q1 2025 in Review

7 institutional investors reported a position in Clearmind Medicine (CMND) for Q1 2025, worth a combined $5.45M — down 0.71% from $5.49M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CMND and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was AdvisorShares Investments, adding an estimated $68.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $54K sold.

  • 7 institutional investors held Clearmind Medicine (CMND) as of Q1 2025, down from 9 in Q4 2024.
  • Funds reported $5.45M of Clearmind Medicine stock for Q1 2025, down 0.71% quarter-over-quarter.
  • 1 fund opened new Clearmind Medicine positions in Q1 2025 and 3 closed out, a net change of -2 holders.
  • The largest Clearmind Medicine buyer in Q1 2025 was AdvisorShares Investments, an estimated $68.8K added.
  • The largest Clearmind Medicine seller in Q1 2025 was Virtu Financial, an estimated $54K sold.

Based on aggregated 13F filings for Q1 2025.